MARIA UY QUIAMBAO: Open Payments
NPI 1619344660 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 29 payments from 10 companies in 2025. Trend: 2023 $1,327 · 2024 $1,241 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $454 |
| Novartis Pharmaceuticals Corporation | 16 | $340 |
| Boston Scientific Corporation | 1 | $49 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Amgen Inc. | 2 | $34 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
Products named: VENASEAL, LEQVIO, WATCHMAN FLX, VERQUVO, REPATHA, FUROSCIX, Kerendia, JARDIANCE.
Industry payments across TX — which companies pay providers there.
